Bioequivalence of Two Different Sources of Eslicarbazepine Acetate (Q66046208)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Bioequivalence of Two Different Sources of Eslicarbazepine Acetate |
clinical trial |
Statements
A Single Center, Single Dose, Open Label, Laboratory Blind, Randomized, Three Period, Six Sequence, Crossover Study to Determine the Bioequivalence of Two Different Sources of Eslicarbazepine Acetate (800 mg) and to Assess the Dose Equivalence of Two Different Dose Strengths of Eslicarbazepine Acetate (200 and 800 mg) in Healthy Subjects (English)
0 references
3 December 2016
0 references
5 January 2017
0 references
24
0 references
18 year
0 references
55 year
0 references